Doctor profile · Federal record
Dr. Stephanie Saxton-Daniels, MD
Dermatology Physician (CMS: Dermatology) · Dallas, TX
- NPI 1578882247
- Accepts Medicare
- MIPS 98.3 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6565 Hillcrest Ave Ste 110
Dallas, TX 752051840
(972) 512-4800
fax (214) 484-9994
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- October 16, 2023
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #P4814
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578882247. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
282
Distinct HCPCS
6
Medicare allowed
$10,178
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 171 | 27 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 37 | 29 | $48 | |
11102 |
Biopsy of related skin growth, first growth | 22 | 20 | $86 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 18 | $90 | |
17110 |
Destruction of skin growth, 1-14 growths | 16 | 15 | $112 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 14 | 14 | $111 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 1.3× the peer median.Open Payments
Industry payments received
All-time total
$1,770
Transactions
81
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 12 | $353.21 | |
| Abbvie INC. | 13 | $258.26 | |
| Arcutis Biotherapeutics, INC. | 19 | $251.05 | |
| Galderma Laboratories, L.P. | 10 | $249.93 | |
| Sun Pharmaceutical Industries INC. | 7 | $140.58 | |
| Lilly USA, LLC | 3 | $73.02 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 4 | $64.86 | |
| Almirall LLC | 2 | $56.94 | |
| Strata Skin Sciences, INC. | 1 | $50.15 | |
| Mayne Pharma Commercial LLC | 3 | $48.65 | |
| Ucb, INC. | 2 | $45.19 | |
| Paratek Pharmaceuticals, INC. | 2 | $39.69 | |
| Verrica Pharmaceuticals INC. | 1 | $35.43 | |
| Regeneron Healthcare Solutions, INC. | 1 | $32.24 | |
| Novartis Pharmaceuticals Corporation | 1 | $24.77 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
17
Patients
0
Total drug cost
$737
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 17 | 0 | $737 |
Frequently asked questions
What is Dr. Stephanie Saxton-Daniels's medical specialty?
Dr. Stephanie Saxton-Daniels practices Dermatology Physician in Dallas, TX.
Where does Dr. Stephanie Saxton-Daniels practice?
Dr. Stephanie Saxton-Daniels practices at 6565 Hillcrest Ave Ste 110, Dallas, TX 752051840. Office phone: 9725124800.
What is Dr. Stephanie Saxton-Daniels's NPI?
Dr. Stephanie Saxton-Daniels's National Provider Identifier (NPI) is 1578882247, issued by NPPES.
Does Dr. Stephanie Saxton-Daniels accept Medicare assignment?
Yes. Dr. Stephanie Saxton-Daniels accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephanie Saxton-Daniels commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.